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ravel medicine and the inﬂuenza pandemic
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. Sotelo Morales
National Autonomous University of Mexico, Mexico City,
exico
In April, 2009 a new inﬂuenza virus, from porcine ori-
in, was detected in Mexico City and blamed as responsible
or the death of young adults with pneumonia. The patients
ere seen within the brief lapse of a week at the National
nstitute of Respiratory Diseases of Mexico; three main fac-
ors contributed to trigger the awakening call from the
exican Health authority that evolved, within a few weeks,
nto an unprecedented international epidemiological alert
rchestrated by the World Health Organization which cul-
inated with the ‘‘Pandemic alert grade VI’’; it meant that
he disease had already disseminated worldwide; the factors
ere: a) the presence of various cases of severe inﬂuenza
n healthy adults, b) the presence of the disease in the
iddle of spring, an abnormal timing for seasonal inﬂuenza
nd c) the identiﬁcation by molecular methods of a brand
ew inﬂuenza virus from porcine origin infecting humans.
ccording to the standards settled by the WHO these char-
cteristics represented the much feared possibility of an
nﬂuenza pandemic of potential catastrophic consequences;
hus, the Ministry of Health of Mexico implemented at mea-
ures which had already been planned two years before
n the case of facing such event. The Minister of Health
ppeared on national TV indicating the closure of schools
t all levels in Mexico City and various other actions aiming
o social distancing and medical alert in all health institu-
ions, together with the development of technical skills for
he reliable detection of the new virus in specialized labora-
ories. Through the epidemic in Mexico several new factors
ere learned, the capacity of society to deal with similar
vents was put to test. From this experience, several scien-
iﬁc reports from our Institutes have been published; they
rovide a new framework for more efﬁcient responses in
uture events.
oi:10.1016/j.ijid.2010.02.1494
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. Dabanch Pena
Hospital Militar de Santiago, Santiago, Chile
In Chile, the ﬁrst case of 2009 pandemic inﬂuenza A
1N1 virus infection was detected on May 17. Since then all
nﬂuenza like illness cases were notiﬁed to Chilean Health
ecretary. A total of 367.041 cases were reported, 1585
equired hospitalization (0.56%) and 130 died.
The surveillance in Chile shows that the majority of those
nfected had a mild disease.
The most affected age group was between 5 and 14.
ebrile respiratory infection was the most common clinical
anifestation and range from self limited to severe illness.
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n the outpatient group, 97% had fever, 97% headache, 93.5%
yalgias, 90% cough, 88.3% sore throat, 84% rhinorrhea,
3.8% join pain, 36% nausea, 29.4% diarrhea. Time between
nset symptoms and second case was 3.6 days (range 1 — 9).
Of the 1585 admitted to hospital, 52% were females,
edian age 33 years (range11 to 94), 56% had underlying
edical condition, average time from the onset of illness
o hospital admission was 3.6 days. Symptoms at presenta-
ion included fever 83%, cough 92.7%, dyspnea 83%, myalgias
3%, hypoxia 50.8%, cyanosis 27.4%, hypotension 18.6%, and
.3% seizures.
Pneumonia was the diagnosis in 77% patients.
130 patients died, all has been admitted to and ICU. The
edian age was 44 years (range 4 months to 89 years), 87.5%
ad underlying medical condition. The cause of death was
evere respiratory failure in 34%, septic shock in 19%, bilat-
ral pneumonia 17% and multi organic failure in 16%. Almost
ll patients received antiviral treatment.
Surveillance in Chile of the 2009 inﬂuenza A H1N1 cases
llow to characterize the clinical spectrum of the disease in
his ﬁrst pandemic wave.
oi:10.1016/j.ijid.2010.02.1495
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. Alves
Institute for Infectious Diseases Emilio Ribas, Sao Paulo,
razil
Through the epidemiological week 37/2009, WHO
eported more than 300,000 conﬁrmed cases and almost
,000 deaths produced by pandemic inﬂuenza H1N1 in 191
fﬁliated countries.
During the peak of transmission in 2009, the Southern
one countries, Chile, Argentina and Southern regions of
razil, reported the highest number of cases. According
o PAHO, through the week 20/2009, 92,773 H1N1 cases
ere conﬁrmed in Latin America as well as in Caribbean
slands and a total of 2,494 deaths had been reported. Brazil
ccounted for the highest number of deaths and an elevated
ortality rate when compared to countries like Chile. Initial
ontainment measures, such as screening symptomatic peo-
le in airports and aircrafts and isolating patients who had
ecently traveled and presented ﬂu-like symptoms, proved
neffective. Different strategies developed in each coun-
ry showed that the early identiﬁcation and treatment of
igh risk patients were responsible for reducing mortality.
lthough some demographic differences and distinctive clin-
cal outcomes were noticed in different countries, various
eports demonstrated that patients with underlying condi-
ions such as asthma, diabetes, cardiac and lung diseases as
ell as pregnant women were more susceptible to complica-
ions. General experience made the beneﬁt of early use of
ntiviral drugs clear. Based on what had been learnt dur-
ng the pandemic and in line with WHO directives, Latin
merica countries are working on a vaccination program
argeting the most vulnerable populations. These countries
ad to deal with a high number of cases earlier than other
egions and before the impact on health care systems could
e observed. Cooperation between countries requires clear
